Dyadic International Inc (DYAI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
37
About the Report
About the Report
Summary
Dyadic International Inc (Dyadic) is a biotechnology company that develops, discovers, manufactures, and commercializes protein-based drugs. The company utilizes its patented and proprietary technology Myceliopthora thermophila expression systems to conduct research and produce industrial enzymes. It works in partnership with pharmaceutical company to develop imperative non-glycosylated therapeutic products such as ranibizumab and insulin with the help of C1 technology. The company serves bioenergy, biochemical, biopharmaceutical, and industrial enzyme industries. It has its operations the US and the Netherlands. Dyadic is headquartered in Jupiter, Florida, the US.
Dyadic International Inc (DYAI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Dyadic International Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dyadic International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dyadic International Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Dyadic International to Enter into Research Agreement with Sanofi-Aventis 10
Dyadic International Enters into Research Agreement with Mitsubishi Tanabe Pharma 11
Dyadic International Enters into R&D Agreement with Israel Institute for Biological Research 12
Dyadic International Enters into R&D Agreement with BDI Holdings 13
Dyadic International Enters into Co-Development Agreement for C1 Technology 14
Licensing Agreements 15
BASF Enters Into Licensing Agreement With Dyadic International For C1 Technology 15
Dyadic International Inc-Key Competitors 16
Dyadic International Inc-Key Employees 17
Dyadic International Inc-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Aug 09, 2018: Dyadic International reports second quarter 2018 financial results 19
May 10, 2018: Dyadic International Reports First Quarter 2018 Financial Results 21
Mar 27, 2018: Dyadic International Announces 2017 Year End Results and Recent Developments 23
Nov 09, 2017: Dyadic International Reports Third Quarter 2017 Financial Results 25
Aug 10, 2017: Dyadic International Reports Second Quarter 2017 Financial Results 27
May 11, 2017: Dyadic International Reports First Quarter 2017 Financial Results 29
Mar 15, 2017: Dyadic International Reports 2016 Financial Results 31
Corporate Communications 33
Mar 15, 2018: Dyadic International Appoints Chief Accounting Officer 33
Jan 03, 2018: Dyadic International Appoints New Board Member 34
Apr 06, 2017: Dyadic Announces Director Resignation 35
Other Significant Developments 36
Jun 05, 2018: Dyadic to Develop Biosimilars Using CHO-Challenging Expression System 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Figure
List of Figures
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
List of Table
List of Tables
Dyadic International Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Dyadic International Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Dyadic International Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Dyadic International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Dyadic International to Enter into Research Agreement with Sanofi-Aventis 10
Dyadic International Enters into Research Agreement with Mitsubishi Tanabe Pharma 11
Dyadic International Enters into R&D Agreement with Israel Institute for Biological Research 12
Dyadic International Enters into R&D Agreement with BDI Holdings 13
Dyadic International Enters into Co-Development Agreement for C1 Technology 14
BASF Enters Into Licensing Agreement With Dyadic International For C1 Technology 15
Dyadic International Inc, Key Competitors 16
Dyadic International Inc, Key Employees 17
Dyadic International Inc, Subsidiaries 18
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.